Panavance Therapeutics Inc. Created to Transform Cancer Trea

Panavance Therapeutics Inc. (“Panavance”) is a new clinical-stage pharmaceutical company created to advance and develop GP-2250, a patented, novel therapeutic for the treatment of cancer and other therapeutic indications...

Related Keywords

Greg Bosch , Chemische Industrie , Panavance Therapeutics Inc , Panavance Therapeutics , Avensis Pharma , Chief Executive Officer ,